AlloStim

allogeneic immunotherapy · Mirror Biologics, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for AlloStim, covering 2011-06-08 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer [Phase 2]